InsiderChief Executive Officer

Eric Venker Insider Trading Activity

Every SEC Form 4 transaction reported by Eric Venker, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Eric Venker buying or selling?

Eric Venker reported 0 open-market buys ($0) and 58 sells ($201.9M) across 58 Form 4 filings at 2 companies — a net selling position of $201.9M.

Source: SEC EDGAR Form 4

What stands out

  • Eric Venker has reported Form 4 transactions at 2 companies; the most active, Roivant Sciences Ltd. (ROIV), accounts for 55 of 58 filings (95%).
  • The most recent Form 4 was accepted on Oct 5, 2026 (13 days ago).
  • In the last 12 months: no open-market purchases and 14 sales ($66.3M).
  • The largest open-market sale in the last 12 months was $7.3M of Roivant Sciences Ltd. (ROIV) on Oct 2, 2026. SEC ↗

Key Statistics (as of Oct 5, 2026)

Total Form 4 filings
58
SEC EDGAR
Companies
2
Buys (0)
$0
Sells (58)
$201.9M

Insider sentiment

Net selling

Net insider flow of $201.9M in net selling, filed between Mar 29, 2022 – Oct 5, 2026.

Companies Eric Venker files for

#CompanyForm 4 filings
1ROIVRoivant Sciences Ltd.55
2IMVTImmunovant, Inc.3

Recent Eric Venker transactions

DateTickerRoleTypeSharesValueFiling
Oct 5, 2026IMVTChief Executive OfficerSale3.5K$119.6KSEC ↗
Oct 2, 2026ROIVPresident & Immunovant CEOSale200.0K$7.3MSEC ↗
Sep 2, 2026ROIVPresident & Immunovant CEOSale200.0K$7.2MSEC ↗
Jul 30, 2026ROIVPresident & Immunovant CEOSale200.0K$7.0MSEC ↗
Jul 6, 2026IMVTChief Executive OfficerSale3.1K$119.0KSEC ↗
Jun 26, 2026ROIVPresident & Immunovant CEOSale200.0K$6.6MSEC ↗
May 22, 2026ROIVPresident & Immunovant CEOSale200.0K$6.1MSEC ↗
Apr 22, 2026ROIVPresident & Immunovant CEOSale200.0K$5.9MSEC ↗
Apr 3, 2026IMVTChief Executive OfficerSale14.2K$342.9KSEC ↗
Mar 19, 2026ROIVPresident & Immunovant CEOSale200.0K$5.6MSEC ↗
Feb 18, 2026ROIVPresident & Immunovant CEOSale200.0K$5.3MSEC ↗
Jan 15, 2026ROIVPresident & Immunovant CEOSale200.0K$4.4MSEC ↗
Dec 30, 2025ROIVPresident & Immunovant CEOSale275.0K$6.2MSEC ↗
Dec 12, 2025ROIVPresident & Immunovant CEOSale200.0K$4.2MSEC ↗
Oct 18, 2025ROIVPresident & Immunovant CEOSale851.4K$14.5MSEC ↗
Oct 15, 2025ROIVPresident & Immunovant CEOSale125.7K$2.0MSEC ↗
Oct 9, 2025ROIVPresident & Immunovant CEOSale665.2K$10.8MSEC ↗
Sep 24, 2025ROIVPresident & Immunovant CEOSale1.7M$25.5MSEC ↗
Aug 23, 2025ROIVPresident & Immunovant CEOSale100.0K$1.2MSEC ↗
Jul 24, 2025ROIVPresident & Immunovant CEOSale100.0K$1.2MSEC ↗
Jun 25, 2025ROIVPresident & COOSale100.0K$1.1MSEC ↗
Jun 5, 2025ROIVPresident & COOSale1.0M$11.2MSEC ↗
May 23, 2025ROIVPresident & COOSale100.0K$1.1MSEC ↗
Apr 23, 2025ROIVPresident & COOSale100.0K$1.0MSEC ↗
Mar 25, 2025ROIVPresident & COOSale750.0K$8.2MSEC ↗

Showing the 25 most recent filings of 58. Screen every filing.

Eric Venker insider trading FAQ

Is Eric Venker buying or selling?

Across 58 SEC Form 4 filings, Eric Venker reported 0 open-market purchases totaling $0 and 58 sales totaling $201.9M — a net selling position of $201.9M.

Which companies does Eric Venker file Form 4s for?

Eric Venker has reported insider transactions at 2 companies, most often Roivant Sciences Ltd. (ROIV), Immunovant, Inc. (IMVT).

How far back does Eric Venker's filing history go?

Trabud holds Eric Venker's SEC Form 4 filings from Mar 29, 2022 – Oct 5, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Eric Venker's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Eric Venker and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener